Literature DB >> 20862487

Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis.

Amandine Benoit, François Ducray, Stéphanie Cartalat-Carel, Dimitri Psimaras, Damien Ricard, Jérôme Honnorat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20862487     DOI： 10.1007/s00415-010-5747-5

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Bevacizumab reverses cerebral radiation necrosis.

Authors:  Eric T Wong; Mark Huberman; Xing-Qi Lu; Anand Mahadevan
Journal:  J Clin Oncol       Date:  2008-11-03       Impact factor: 44.544

Review 2.  CNS complications of radiotherapy and chemotherapy.

Authors:  Carole Soussain; Damien Ricard; John R Fike; Jean-Jacques Mazeron; Dimitri Psimaras; Jean-Yves Delattre
Journal:  Lancet       Date:  2009-11-07       Impact factor: 79.321

3.  Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.

Authors:  Victor A Levin; Luc Bidaut; Ping Hou; Ashok J Kumar; Jeffrey S Wefel; B Nebiyou Bekele; Jai Grewal; Sujit Prabhu; Monica Loghin; Mark R Gilbert; Edward F Jackson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-01       Impact factor: 7.038

4.  Effect of bevacizumab on radiation necrosis of the brain.

Authors:  Javier Gonzalez; Ashok J Kumar; Charles A Conrad; Victor A Levin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-01       Impact factor: 7.038

5.  Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.

Authors:  Roy Torcuator; Richard Zuniga; Yedathore S Mohan; Jack Rock; Thomas Doyle; Joseph Anderson; Jorge Gutierrez; Samuel Ryu; Rajan Jain; Mark Rosenblum; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2009-02-03       Impact factor: 4.130

6.  Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.

Authors:  Arthur K Liu; Margaret E Macy; Nicholas K Foreman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-15       Impact factor: 7.038
  6 in total
  12 in total

1.  An analysis of radiation necrosis of the central nervous system treated with bevacizumab.

Authors:  Karen Tye; Herbert H Engelhard; Konstantin V Slavin; M Kelly Nicholas; Steven J Chmura; Young Kwok; Dominic S Ho; Ralph R Weichselbaum; Matthew Koshy
Journal:  J Neurooncol       Date:  2014-02-07       Impact factor: 4.130

Review 2.  Delayed brain radiation necrosis: pathological review and new molecular targets for treatment.

Authors:  Motomasa Furuse; Naosuke Nonoguchi; Shinji Kawabata; Shin-Ichi Miyatake; Toshihiko Kuroiwa
Journal:  Med Mol Morphol       Date:  2015-12       Impact factor: 2.309

3.  Low-dose bevacizumab as an effective pre-treatment for peri-tumoral brain edema prior to CyberKnife radiosurgery: A case report.

Authors:  Meng Xiangying; Zhao Rugang; Ding Lijuan; Zhao Yaowei; Sun Bing; Wang Junliang; Li Dan; Wu Shikai
Journal:  Cancer Biol Ther       Date:  2018-03-21       Impact factor: 4.742

4.  Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery.

Authors:  Christopher P Deibert; Manmeet S Ahluwalia; Jason P Sheehan; Michael J Link; Toshinori Hasegawa; Shoji Yomo; Wu Han Feng; Pan Li; John C Flickinger; L Dade Lunsford; Douglas Kondziolka
Journal:  J Neurooncol       Date:  2013-08-09       Impact factor: 4.130

Review 5.  Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management.

Authors:  Jing Chen; Meera Dassarath; Zhongyuan Yin; Hongli Liu; Kunyu Yang; Gang Wu
Journal:  Radiat Oncol       Date:  2011-09-30       Impact factor: 3.481

Review 6.  Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature.

Authors:  Durim Delishaj; Stefano Ursino; Francesco Pasqualetti; Agostino Cristaudo; Mirco Cosottini; Maria Grazia Fabrini; Fabiola Paiar
Journal:  J Clin Med Res       Date:  2017-02-21

7.  Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.

Authors:  Muhammad Khan; Zhihong Zhao; Sumbal Arooj; Guixiang Liao
Journal:  BMC Cancer       Date:  2021-02-16       Impact factor: 4.430

8.  Bilateral thalamic and mesencephalic infarctions with hypopituitarism as long-term complications postradiotherapy: A case report.

Authors:  Liang Hui; Hu Shijun; Liu Tao; Wen Guoqiang; Huang Shixiong
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

9.  Genome-Wide Association Study of Susceptibility Loci for Radiation-Induced Brain Injury.

Authors:  Tong-Min Wang; Guo-Ping Shen; Ming-Yuan Chen; Jiang-Bo Zhang; Ying Sun; Jing He; Wen-Qiong Xue; Xi-Zhao Li; Shao-Yi Huang; Xiao-Hui Zheng; Shao-Dan Zhang; Ye-Zhu Hu; Hai-De Qin; Jin-Xin Bei; Jun Ma; Jianbing Mu; Yin Yao Shugart; Wei-Hua Jia
Journal:  J Natl Cancer Inst       Date:  2019-06-01       Impact factor: 13.506

Review 10.  Radiation induced temporal lobe necrosis in nasopharyngeal cancer patients after radical external beam radiotherapy.

Authors:  Vincent W C Wu; Shing-Yau Tam
Journal:  Radiat Oncol       Date:  2020-05-15       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.